Clinical Trials

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05834348 2025-03-30

DELINOR

Completed

5,279 enrolled 10 charts

GastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung

NCT02876510 2025-02-04

ACTolog

Phase 1 Completed

38 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04462276 2025-01-30

TREASURE

68 enrolled

Small Cell Lung Cancer Extensive Stage

NCT03285763 2025-01-23

TAIL

Phase 4 Completed

619 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT04920981 2024-11-07

CLINATEZO

Completed

518 enrolled

Small Cell Lung Carcinoma

NCT03191786 2024-10-23

IPSOS

453 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung

NCT03526900 2024-10-09

ATEZO-BRAIN

40 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT04924374 2024-09-26

Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy

Phase NA Completed

25 enrolled

GastrointestinalGenitourinaryThoracic

Lung Neoplasms, Neoplasms

NCT04713891 2024-09-24

A Study of KF-0210 in Advanced Solid Tumors Patients

Phase 1 Completed

14 enrolled

Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02927301 2024-09-19

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

181 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT03689855 2024-07-30

RamAtezo-1

21 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT04622228 2024-07-29

Match

56 enrolled

Small Cell Lung Carcinoma

NCT04194203 2024-07-19

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

305 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04028050 2024-07-16

MAURIS

155 enrolled

Small Cell Lung Carcinoma

NCT04730999 2024-07-05

CeLEBrATE

54 enrolled

Small Cell Lung Carcinoma

NCT04480372 2024-07-01

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Other solid neoplasmThoracic

68 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT04321330 2024-06-11

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

34 enrolled

Thymoma

NCT04426825 2024-05-21

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

23 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung

NCT03976518 2024-03-01

CHANCE

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03511391 2024-01-23

CHEERS

DermatologicGenitourinaryHead & NeckThoracic

99 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

NCT03014648 2023-12-13

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

28 enrolled 22 charts

Advanced Non-small Cell Lung Cancer

NCT02716038 2023-12-12

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

39 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT02657434 2023-11-21

A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)

578 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT02994576 2023-09-29

PRINCEPS

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03559647 2023-09-01

The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy

Completed

358 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02763579 2023-07-28

IMpower133

503 enrolled 23 charts 2 FDA

Small Cell Lung Carcinoma

NCT03102242 2023-05-24

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

64 enrolled 12 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Carcinoma, Non-Small-Cell Lung

NCT03841110 2023-05-01

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Phase 1 Completed

37 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

NCT02409342 2023-03-15

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

572 enrolled 32 charts 3 FDA

Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

NCT04059887 2023-02-08

BUDDY

Phase 4 Completed

100 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02813785 2023-01-10

IMpower210

565 enrolled